Skin-cancer vaccine shows promise; America’s government debt passes $40trn, and more

from The World in Brief from The Economist

Moderna and Merck, two American pharma companies, reported successful interim results in the trial of a personalised skin-cancer vaccine. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Aug 20, 2026

Embed this episode

Attribution link and audio player

Ready to play

Skin-cancer vaccine shows promise; America’s government debt passes $40trn, and more

0:00 4:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The World in Brief from The Economist?

This episode is 4 minutes long.

When was this The World in Brief from The Economist episode published?

This episode was published on August 20, 2026.

Can I download this The World in Brief from The Economist episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!